(4S)-3-(5-(1,3-DIOXOLAN-2-YL)-6,7-DIFLUORO-1,2-BENZISOXAZOL-3-YL)-4-METHYL-2-OXAZOLIDINONE
UNII W2MMX7XP62
Substance Identification & Data
This profile provides standardized clinical and technical data for (4s)-3-(5-(1,3-dioxolan-2-yl)-6,7-difluoro-1,2-benzisoxazol-3-yl)-4-methyl-2-oxazolidinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W2MMX7XP62.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1802089-90-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C14H12F2N2O5 BWYDYEKEFNTKOA-LURJTMIESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (4s)-3-(5-(1,3-dioxolan-2-yl)-6,7-difluoro-1,2-benzisoxazol-3-yl)-4-methyl-2-oxazolidinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.